You are here

  • Home
  • Archive
  • Volume 87, Issue Suppl 1
  • M1 Deutetrabenazine: update on first time use of SD-809 in huntington’s disease (First-HD) and alternative for reducing chorea in huntington’s disease (ARC-HD)

Article info

Article menu
Download PDFPDF
Clinical Therapeutics
M1 Deutetrabenazine: update on first time use of SD-809 in huntington’s disease (First-HD) and alternative for reducing chorea in huntington’s disease (ARC-HD)

Authors

Citation

Testa C, on behalf of the Huntington Study Group
M1 Deutetrabenazine: update on first time use of SD-809 in huntington’s disease (First-HD) and alternative for reducing chorea in huntington’s disease (ARC-HD)
Journal of Neurology, Neurosurgery & Psychiatry 2016;87:A101.

Publication history

  • First published September 13, 2016.
Online issue publication 
September 13, 2016

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© 2016, Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions